Bioniq funding news – London-based Bioniq Secures investment from Cristiano Ronaldo

Ronaldo Role in Bioniq

Ronaldo who joined Bioniq in 2022 and uses its supplements packed with nutrients on a daily basis for several years now, keeping with the theme of this investment, makes it clear how important it is for him to enhance his health and performance on and off the field.

Additionally, he is an advocate for the intake of vitamins, minerals and other dietary supplements among professional athletes and active individuals. In fact, he is expected to be involved in the planning of brand and product development in the future.

Its patented algorithm is complemented by advanced technologies and leading scientists for the purpose of assisting users in over 70 countries with Bioniq’s cutting-edge method which aims to reach over 5 million active users by 2024. Bioniq personalized supplements, synthesizing advanced blood biomarker analysis and self-reported health data, revolutionizes the approach to managing individual health.

Read also - Oriole Networks funding news – London-based Oriole Networks Secures an Additional €20.2 Million Funding

As part of the platform's shift towards precision, the start-up specializes in developing a custom made formulation for each user which is taken on a daily basis to fulfill some of the body’s basic nutritional requirements and enables them to have elevated nutrient levels over a period of time.

Cristiano Ronaldo stated, "Supporting Bioniq goes beyond just an investment opportunity for me—it's about aligning with a shared vision for health, performance, and longevity. I have been using their products myself for almost three years. With their personalized health approach, I believe Bioniq has the potential to transform how we care for our bodies and help people reach and maintain their peak performance for longer."

Funding Purpose

Ronaldo's endorsement is of great value to Bioniq as it paves way for global advancement especially in the United States, Europe and the Middle East enhancing creativity in wellness market which is gaining prominence with the US now accounting for over 60% of the total global sales. As a professional athlete, he has had a very specific performance need at every stage of his career, and this sort of intuition very capitalistically aids it's product offering.

Worthy of note is his tremendous input on how to tailor health solutions to diverse users as he has participated in sport at different competitive ages. His contributions will help advance the firm’s aim of providing millions with online precision nutrition that will help them embrace great health and wellbeing.

Vadim Fedotov, Co-Founder and CEO of Bioniq said, “Cristiano Ronaldo is the perfect partner and shareholder. As the ultimate embodiment of performance and longevity, Cristiano fully aligns with the values and mission of Bioniq, We are thrilled that the world’s leading athlete and advocate of a healthy lifestyle has made Bioniq part of his journey since 2022. His personal experience with our products reinforces his belief in what we’re building. Cristiano’s decision to invest, highlights his confidence in our team’s vision and his commitment to helping us build the leading company in personalized health.”

It has constructed its largest proprietary biochemical database, utilizing blood test data from customers across five continents. This follows Ronaldo's investment and a successful Series B, which raised $15 million, led by Principal Investors HV Capital and Unbound, two prominent European VCs.

David Kuczek, General Partner at HV Capital said, “The personalized health and nutrition market is expansive, and Bioniq is leading the way with its innovative approach to personalization, Cristiano using Bioniq to enhance his performance shows that our product delivers real results. If it works for an elite athlete of his caliber, it’s clear that it can benefit ambitious consumers, helping them reach their own health and performance goals.”

About Bioniq

Bioniq, an innovative health tech company. It is leading the way to the future of personalized health. Their proprietary biochemical database and patented technology enable them to design completely personalized solutions for health optimization.